Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Intravitreal bevacizumab in choroidal neovascularization associated with Best's vitelliform dystrophy.

Mandal S, Sinha S, Venkatesh P, Vashisht N.

Indian J Ophthalmol. 2011 May-Jun;59(3):262-3. doi: 10.4103/0301-4738.81034. No abstract available.

2.

[Intravitreal bevacizumab for choroidal neovascularization associated with Best's disease].

Velazquez-Villoria D, Macià Badia C, Rigo Quera J, Velez-Escola L, Arcos-Algaba G, Martínez-Castillo V, García-Arumí J.

Arch Soc Esp Oftalmol. 2014 Oct;89(10):405-7. doi: 10.1016/j.oftal.2013.07.002. Epub 2014 Feb 5. Spanish.

PMID:
24508228
3.

[Intravitreal bevacizumab treatment for choroidal neovascularization in Best's disease].

Perol J, Wolff B, Sahel JA, Le Mer Y.

J Fr Ophtalmol. 2011 May;34(5):281-6. doi: 10.1016/j.jfo.2010.11.021. Epub 2011 Apr 20. French.

4.

Long-term outcomes of intravitreal ranibizumab for choroidal neovascularization secondary to Best's disease: 3-year follow-up.

Ruiz-Moreno O, Calvo P, Ferrández B, Torrón C.

Acta Ophthalmol. 2012 Nov;90(7):e574-5. doi: 10.1111/j.1755-3768.2011.02363.x. Epub 2012 Feb 17. No abstract available.

5.

Intravitreal bevacizumab for choroidal neovascular membrane associated with Best's vitelliform dystrophy.

Rishi E, Rishi P, Mahajan S.

Indian J Ophthalmol. 2010 Mar-Apr;58(2):160-2. doi: 10.4103/0301-4738.60096.

6.

Choroidal neovascular membrane in Best juvenile dystrophy treated with intravitreal bevacizumab.

Taban C, Merticariu A, Melcioiu L, Oprescu A, Ionescu R, Iacob A, Pienaru M, Desliu D, Balta F.

Oftalmologia. 2013;57(3):47-51, 42-6. English, Romanian. No abstract available.

PMID:
24701814
7.

[Intravitreal ranibizumab for choroidal neovascularisation associated with adult-onset vitelliform dystrophy].

Prieto-Calvo E, Torrón-Fernández Blanco C, Egea-Estopiñán C, Güerri-Monclús N, Ferrer-Novella E, Ruiz-Moreno O, Pablo-Julvez LE.

Arch Soc Esp Oftalmol. 2012 May;87(5):149-52. doi: 10.1016/j.oftal.2011.09.009. Epub 2012 Feb 9. Spanish.

PMID:
22554558
8.

Functional and anatomic changes in bilateral choroidal neovascularization associated with vitelliform macular dystrophy after intravitreal bevacizumab.

Cennamo G, Cesarano I, Vecchio EC, Reibaldi M, de Crecchio G.

J Ocul Pharmacol Ther. 2012 Dec;28(6):643-6. doi: 10.1089/jop.2011.0250. Epub 2012 Jun 28.

PMID:
22742532
9.

Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child.

Chhablani J, Jalali S.

Eur J Ophthalmol. 2012 Jul-Aug;22(4):677-9. doi: 10.5301/ejo.5000095.

PMID:
22139615
10.

Choroidal neovascularisation secondary to Best's disease in a 13-year-old boy treated by intravitreal bevacizumab.

Leu J, Schrage NF, Degenring RF.

Graefes Arch Clin Exp Ophthalmol. 2007 Nov;245(11):1723-5. Epub 2007 Jun 29.

PMID:
17605026
11.

Intravitreal ranibizumab for type 3 choroidal neovascularization complicating adult onset foveomacular vitelliform dystrophy.

Querques G, Querques L, Leveziel N, Bandello F, Souied EH.

J Fr Ophtalmol. 2013 Jan;36(1):e1-4. doi: 10.1016/j.jfo.2012.04.013. Epub 2012 Dec 4.

12.

Intravitreal bevacizumab for choroidal neovascularization associated with a retinochoroidal coloboma.

Rajendran A, Gupta SR, Brahadeesh S, Ramasamy K.

Eye (Lond). 2010 May;24(5):933-4. doi: 10.1038/eye.2009.221. Epub 2009 Aug 28. No abstract available.

PMID:
19713977
13.

[Choroidal neovascularization complicating Best's vitelliform macular dystrophy in a child].

Elkhoyaali A, Chatoui S, Bercheq N, Elouatassi N, Zerrouk R, Elasri F, Reda K, Oubaaz A.

J Fr Ophtalmol. 2016 Jan;39(1):69-73. doi: 10.1016/j.jfo.2015.05.008. Epub 2015 Dec 18. French.

PMID:
26707756
14.

Autosomal recessive best vitelliform macular dystrophy: report of a family and management of early-onset neovascular complications.

Iannaccone A, Kerr NC, Kinnick TR, Calzada JI, Stone EM.

Arch Ophthalmol. 2011 Feb;129(2):211-7. doi: 10.1001/archophthalmol.2010.367.

PMID:
21320969
15.

[Best's vitelliform macular dystrophy associated with choroidal neovascularization].

Céspedes A, Pérez-De-Arcelus M, García-Arumí J.

Arch Soc Esp Oftalmol. 2012 Oct;87(10):333-6. doi: 10.1016/j.oftal.2011.11.010. Epub 2012 Mar 14. Spanish.

PMID:
23021232
16.

Treatment of choroidal neovascularization associated with Best's disease in children.

Rich R, Vanderveldt S, Berrocal AM, Mavrofrides EC, Murray TG, Gregori N.

J Pediatr Ophthalmol Strabismus. 2009 Sep-Oct;46(5):306-11. doi: 10.3928/01913913-20090903-10. Epub 2009 Sep 22.

PMID:
19791730
17.

[Intravitreal Bevacizumab injections in a child with choroidal neovascularization--case report].

Krzyzanowska-Berkowska P, Barć A, Oficjalska J.

Klin Oczna. 2011;113(1-3):60-3. Polish.

PMID:
21853954
18.

Intravitreal bevacizumab (Avastin) for the treatment of choroidal neovascularization in age-related macular degeneration: results from 118 cases.

Madhusudhana KC, Hannan SR, Williams CP, Goverdhan SV, Rennie C, Lotery AJ, Luff AJ, Newsom RS.

Br J Ophthalmol. 2007 Dec;91(12):1716-7. No abstract available.

19.

Intravitreal bevacizumab for parapapillary choroidal neovascularization due to exudative age-related macular degeneration.

Jonas JB, Tao Y, Rensch F.

Acta Ophthalmol. 2011 Feb;89(1):e105-7. doi: 10.1111/j.1755-3768.2009.01820.x. No abstract available.

20.

Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy.

Mandal S, Sinha S, Abbas Z, Venkatesh P.

Indian J Ophthalmol. 2011 Jul-Aug;59(4):338-9. doi: 10.4103/0301-4738.82021. No abstract available.

Supplemental Content

Support Center